Monkeypox Testing Market Size, Share, Trends, Growth Outlook

Monkeypox Testing Market is estimated to increase at a growth rate of 4.6% CAGR over the forecast period from 2024 to 2030.

The global Monkeypox Testing Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Technology (Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Others), By End-user (Hospitals and Clinics, Diagnostic Laboratories, Others).

An introduction to Monkeypox Testing Market in 2024

The Monkeypox Testing market experiences significant growth in 2024, driven by the global efforts to mitigate the spread of emerging infectious diseases and enhance epidemic preparedness and response capabilities. Monkeypox, caused by the monkeypox virus, poses a public health threat due to its potential for human-to-human transmission and outbreaks in susceptible populations. Timely and accurate diagnostic testing plays a crucial role in identifying cases, implementing control measures, and monitoring disease transmission dynamics. Market dynamics are shaped by factors such as the increasing incidence of zoonotic diseases, the development of rapid diagnostic tests for point-of-care and laboratory settings, and the collaborative efforts of healthcare agencies, research organizations, and diagnostic companies to combat emerging infectious threats. Collaboration fosters innovation in the Monkeypox Testing market, leading to the development of robust diagnostic assays, surveillance tools, and laboratory infrastructure to detect and respond to monkeypox outbreaks effectively and safeguard public health.

Monkeypox Testing Market Trend: Increased Surveillance and Testing

A significant trend in the Monkeypox Testing Market is the increased emphasis on surveillance and testing for monkeypox virus infection, driven by the sporadic outbreaks and potential for zoonotic transmission. With the emergence of monkeypox as a public health concern, there's a growing need for robust surveillance systems and diagnostic testing capabilities to monitor and detect cases of monkeypox virus infection in both human and animal populations. This trend reflects the proactive approach of healthcare authorities and veterinary agencies in implementing surveillance programs and conducting diagnostic testing to identify and contain monkeypox outbreaks promptly. The increased focus on surveillance and testing drives market demand for monkeypox testing solutions and technologies tailored to rapid and accurate detection of the virus.

Monkeypox Testing Market Driver: Global Health Security Concerns

A key driver in the Monkeypox Testing Market is the global health security concerns surrounding emerging infectious diseases, including monkeypox, which pose threats to public health, biosecurity, and international travel. Monkeypox outbreaks have occurred in several countries, highlighting the potential for cross-border spread and the need for preparedness and response measures to mitigate the risk of transmission. The fear of pandemics and the desire to prevent the spread of infectious diseases drive investment in monkeypox testing infrastructure, research, and development of diagnostic assays and testing kits. The imperative to safeguard global health security and prevent the spread of monkeypox virus fuels market demand for testing solutions and technologies that enable rapid and accurate detection of the virus.

Monkeypox Testing Market Opportunity: Development of Point-of-Care Testing

An emerging opportunity in the Monkeypox Testing Market lies in the development of point-of-care testing (POCT) solutions for rapid and decentralized detection of monkeypox virus infection in resource-limited and remote settings. POCT devices and assays offer the advantages of portability, simplicity, and rapid turnaround time, allowing for timely diagnosis and triage of suspected monkeypox cases in the field, clinics, or community healthcare settings. By providing healthcare providers with actionable diagnostic information at the point of care, POCT solutions can facilitate prompt patient management, infection control measures, and outbreak response efforts, thereby enhancing public health preparedness and containment of monkeypox outbreaks. Investing in the development of POCT for monkeypox testing presents opportunities for stakeholders to address unmet needs in infectious disease diagnostics, improve access to testing in underserved regions, and contribute to global health security initiatives aimed at preventing and controlling emerging infectious diseases.

Monkeypox Testing Market Market Segmentation

By Technology
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
By End-user
Hospitals and Clinics
Diagnostic Laboratories
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Monkeypox Testing Market Companies

Aegis Sciences Corp
Becton, Dickinson and Company
Chembio Diagnostics Inc
Laboratory Corp of America Holdings
Mayo Clinic Laboratories
QIAGEN
Quest Diagnostics Inc
Sonic Healthcare Ltd
Sonora Quest Laboratories
Thermo Fisher Scientific

Reasons to Buy the Monkeypox Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Monkeypox Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Monkeypox Testing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Monkeypox Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Monkeypox Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Monkeypox Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Monkeypox Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Monkeypox Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Monkeypox Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Monkeypox Testing Industry
4.2 Key Market Trends in Monkeypox Testing Industry
4.3 Potential Opportunities in Monkeypox Testing Industry
4.4 Key Challenges in Monkeypox Testing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Monkeypox Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Monkeypox Testing Market Outlook by Segments
7.1 Monkeypox Testing Market Outlook by Segments, $ Million, 2021- 2030
By Technology
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
By End-user
Hospitals and Clinics
Diagnostic Laboratories
Others

8 North America Monkeypox Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America Monkeypox Testing Markets in 2024
8.2 North America Monkeypox Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Monkeypox Testing Market size Outlook by Segments, 2021-2030
By Technology
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
By End-user
Hospitals and Clinics
Diagnostic Laboratories
Others

9 Europe Monkeypox Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Monkeypox Testing Markets in 2024
9.2 Europe Monkeypox Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Monkeypox Testing Market Size Outlook by Segments, 2021-2030
By Technology
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
By End-user
Hospitals and Clinics
Diagnostic Laboratories
Others

10 Asia Pacific Monkeypox Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Monkeypox Testing Markets in 2024
10.2 Asia Pacific Monkeypox Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Monkeypox Testing Market size Outlook by Segments, 2021-2030
By Technology
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
By End-user
Hospitals and Clinics
Diagnostic Laboratories
Others

11 South America Monkeypox Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America Monkeypox Testing Markets in 2024
11.2 South America Monkeypox Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Monkeypox Testing Market size Outlook by Segments, 2021-2030
By Technology
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
By End-user
Hospitals and Clinics
Diagnostic Laboratories
Others

12 Middle East and Africa Monkeypox Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Monkeypox Testing Markets in 2024
12.2 Middle East and Africa Monkeypox Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Monkeypox Testing Market size Outlook by Segments, 2021-2030
By Technology
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
By End-user
Hospitals and Clinics
Diagnostic Laboratories
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Aegis Sciences Corp
Becton, Dickinson and Company
Chembio Diagnostics Inc
Laboratory Corp of America Holdings
Mayo Clinic Laboratories
QIAGEN
Quest Diagnostics Inc
Sonic Healthcare Ltd
Sonora Quest Laboratories
Thermo Fisher Scientific
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Technology
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
By End-user
Hospitals and Clinics
Diagnostic Laboratories
Others